US EditionPublished • loading... • Updated
Gerosynth Labs Announces Investigational New Animal Drug (INAD) Acceptances Spanning Equine, Feline, and Canine Oncology
Summary by chicagostarmedia.com
3 Articles
3 Articles
guymondailyherald.com+2 Reposted by 2 other sources
Gerosynth Labs Announces Investigational New Animal Drug (INAD) Acceptances Spanning Equine, Feline, and Canine Oncology
BLOOMINGTON, Minn., Dec. 11, 2025 /PRNewswire/ -- Gerosynth Labs, Inc., a private biotechnology company pioneering novel oncology and cellular-health therapeutics, today announced that the U.S. Food and Drug Administration Center for Veterinary Medicine (CVM) has accepted multiple Investigational New Animal…
·Guymon, United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
